Arrowhead Pharmaceuticals, Inc. ARWR
Regular-session close
After hours · Nov 20, 4:09 PM ET
- YTD
- -37.69%
- 1 year
- +8.61%
Held by funds
198 US ETFs and mutual funds hold ARWR · largest positions
- NJH 0.31% of fund $368.10M
- NJM 0.29% of fund $230.67M
- IJH 0.19% of fund $225.62M
- VTI 0.01% of fund $201.79M
- VB 0.10% of fund $180.20M
- FGCKX 0.17% of fund $174.31M
- VBK 0.23% of fund $100.88M
- VXF 0.10% of fund $96.00M
- XBI 0.83% of fund $80.91M
- NLO 0.55% of fund $80.55M
- XMMO 1.27% of fund $77.83M
- NNK 0.60% of fund $66.02M
- MDY 0.19% of fund $46.79M
- IBB 0.42% of fund $45.86M
- FSMAX 0.11% of fund $42.29M
- IJK 0.38% of fund $38.55M
- SPMD 0.18% of fund $34.34M
- FSMDX 0.07% of fund $33.41M
- SCHA 0.15% of fund $33.36M
- VEXRX 0.13% of fund $28.84M
Ownership
- Institutions 86.9%
- Insiders 3.65%
- Public and other holders 9.48%
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 10.71% | 15,140,840 | 626.38M | Sep 29, 2026 |
| Avoro Capital Advisors LLC | 7.78% | 11,000,000 | 455.07M | Sep 29, 2026 |
| FMR, LLC | 6.62% | 9,355,747 | 387.05M | Sep 29, 2026 |
| Vanguard Portfolio Management LLC | 4.39% | 6,210,955 | 256.95M | Sep 29, 2026 |
| State Street Corporation | 4.33% | 6,122,271 | 253.28M | Sep 29, 2026 |
| Vanguard Capital Management LLC | 4.33% | 6,118,719 | 253.13M | Sep 29, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Core S&P Mid-Cap ETF | 3.56% | 5,031,501 | 208.15M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.00% | 4,246,637 | 175.68M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.17% | 3,067,819 | 126.92M | Jun 29, 2026 |
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund | 1.88% | 2,663,269 | 110.18M | Sep 29, 2026 |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 1.27% | 1,788,396 | 73.99M | Sep 29, 2026 |
| Invesco Exchange-Traded Fund Trust-Invesco S&P MidCap Momentum ETF | 1.27% | 1,799,303 | 74.44M | Sep 29, 2026 |
Included in Plus and up
Sign in to see Institutional ownership
How much funds own from their 13F filings, quarter by quarter, and the largest holders.
Free with an account
Sign in to see Insider activity
Two years of insider buying and selling by month, marked on the price.
Included in Plus and up
Sign in to see Congress trading
Every stock trade disclosed by members of the US Senate and House.
Leadership team
Who runs ARWR, and what each was last paid
Christopher R. Anzalone, Chairman, Chief Executive Officer & PresidentAverage age 62
| Name | Title | Pay | Age |
|---|---|---|---|
| Christopher R. Anzalone | Chairman, Chief Executive Officer & President | $2.22M | 57 |
| Patrick O'Brien | COO & Secretary | $1.05M | 62 |
| Daniel J. Apel | Chief Financial Officer | $1.04M | 60 |
| James C. Hamilton | Chief Medical Officer and Head of R&D | $987K | 47 |
| Bruce D. Given | Chief Medical Scientist | $486K | 72 |
| Mark Davis | Founder and Founder & Director of Insert Therapeutics Inc & Calando | — | — |
| Mark Seefeld | Head of Toxicology & Vice President | — | 72 |
| Vincent Anzalone | Head of Investor Relations & Vice President | — | — |
| Tao Pei | Chief Scientific Officer | — | — |
| Howard Lovy | Director of Communications | — | — |
Pay is the latest total FMP has for each person (salary, bonus, stock and other awards) and can lag the newest proxy statement. Source: Financial Modeling Prep, from the company’s SEC filings.
Free with an account
Sign in to see CEO compensation
What the chief executive was paid each year, by salary, bonus and stock, beside the company's earnings.
Free with an account
Sign in to see Board of directors
Who sits on the board, who chairs it, and how long each director has served.
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ANZALONE CHRISTOPHER RICHARD | Chief Executive Officer | Sale | Jan 1, 2026 | 3,792,740 |
| APEL DANIEL JOSEPH | Chief Financial Officer | Sale | Apr 21, 2026 | 162,905 |
| FERRARI MAURO | Director | Sale | Dec 25, 2025 | 69,053 |
| GIVEN DOUGLAS BRUCE | Director | Sale | Dec 16, 2024 | 124,167 |
| HAMILTON JAMES C | Officer | Sale | Apr 22, 2026 | 226,958 |
| LU HONGBO B | Director | Sale | May 11, 2026 | 52,012 |
